Ginkgo Bioworks Newsroom

Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology

Yahoo FinanceSep 18 19:01

Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development

BenzingaSep 18 01:48

Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Why

BenzingaSep 17 23:17

Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology

PR NewswireSep 17 20:01

Ginkgo Bioworks Executive Sells Over $1,900 in Stock

InvestingSep 17 04:34

Is Ginkgo Bioworks Holdings, Inc. (DNA) A Good High Risk High Reward Growth Stock To Buy?

Yahoo FinanceSep 14 01:50

Ginkgo Bioworks Awarded $118M U.S. Government HHS Contract

BenzingaSep 10 03:32

Ginkgo Regains Compliance With NYSE Minimum Bid Price Requirement

PR NewswireSep 5 04:30

NYSE to Commence Delisting Proceedings With Respect to the Warrants of Ginkgo Bioworks Holdings, Inc. (DNA.WS)

BusinesswireSep 5 04:05

2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock

Yahoo FinanceSep 3 20:45

Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

PR NewswireAug 30 19:00

Stocks Hitting All-time Highs: JPM, KO, LMT, UNH, and More

Seeking AlphaAug 29 01:55

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Maintains Target Price $7

BTIG analyst Mark Massaro maintains $Ginkgo Bioworks(DNA.US)$ with a sell rating, and maintains the target price at $7.According to TipRanks data, the analyst has a success rate of 31.4% and a total

Futu NewsAug 27 18:31 · Ratings

Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?

Yahoo FinanceAug 24 22:11

BTIG Maintains Sell on Ginkgo Bioworks Holdings, Adjusts Price Target To $7 (1-40 Reverse Stock Split)

BenzingaAug 24 01:17 · Ratings

Ginkgo Bioworks Holdings Analyst Ratings

BenzingaAug 24 01:10 · Ratings

BTIG Maintains Ginkgo Bioworks(DNA.US) With Sell Rating, Cuts Target Price to $7

BTIG analyst Mark Massaro maintains $Ginkgo Bioworks(DNA.US)$ with a sell rating, and adjusts the target price from $8 to $7.According to TipRanks data, the analyst has a success rate of 31.4% and a

Futu NewsAug 23 19:31 · Ratings

Ginkgo Bioworks Holdings: Sell Rating Affirmed With Revised Valuation and Price Target

TipRanksAug 23 19:05 · Ratings

Express News | Ginkgo Bioworks Holdings Inc : Btig Adjusts Target Price to $7 From $0.2 to Reflect 1-for-40 Reverse Stock Split

BreakingsAug 23 12:28

Why We're Not Concerned Yet About Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) 31% Share Price Plunge

Simply Wall StAug 21 18:46